Certified by Founder Lodge
Versant Ventures
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $142,000,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology c
| Company | Date | Round | Raised |
|---|---|---|---|
Light Horse Therapeutics |
January, 10 ,2025 | Series A | $62,000,000 |
Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
AllRock Bio |
September, 17 ,2025 | Series A | $50,000,000 |
Kate Therapeutics |
June, 08 ,2023 | Series A | $51,000,000 |
Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
Santa Ana Bio, Inc. |
June, 14 ,2024 | Series A | $168,000,000 |
858 Therapeutics |
September, 27 ,2024 | Series B | $50,000,000 |
Light Horse Therapeutics |
January, 10 ,2025 | Series A | $62,000,000 |
AllRock Bio |
September, 17 ,2025 | Series A | $50,000,000 |
Light Horse Therapeutics
Abdera Therapeutics
AllRock Bio
Kate Therapeutics
Gate Bioscience
Santa Ana Bio, Inc.
858 Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Combat Medical Ltd | $3,472,639 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Mantis Space | $10,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)